REmote Symptom COllection to improVE postopeRative Care
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Medstar Health Research Institute
- Study ID
- NCT06190730
- Status
- Recruiting
Conditions
- Gastrointestinal Cancer
- Gastrointestinal Surgery
- Gastrointestinal Tumor
- Gastrointestinal Tumor Surgery
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Voice-Assisted Remote Symptom Monitoring System (VARSMS) — OTHERUtilizing an Alexa Skill activated via an Amazon Echo Dot device, this system will administer two patient-reported outcomes measures to subjects. This will not be used as basis for diagnosis, nor for any clinical intervention.
Study Details
There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.
Key Dates
- Start date
- Jul 23, 2024
- Status verified
- Jan 2025
- Primary completion
- Sep 30, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 281 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: ControlBesides the consent process, subjects in this arm will have no other research-specific activities until after 40 days after the surgery for an exit interview.
- Experimental: Voice-Assisted Remote Symptom Monitoring System (VARSMS) groupSubjects in this group will be issued the device, to be activated 1 day after discharge. The device will administer a set of questions daily.
Primary Outcome Measure
Custom questionnaire based on NCI PRO CTCAE (National Cancer Institute- Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events) [ Time Frame: 40 days ]
Central Contacts
- Nawar Shara, PhD301-502-0339
- Crisanto Macaraeg, MD410-261-8218
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MedStar Health | Baltimore | Maryland | 21218 | - |
| Creighton University | Omaha | Nebraska | 68124 | - |
Find similar trials in Baltimore, MD
By research site
Related Studies
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesPHASE1 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland